MYEZOM 2

Myezom 2mg Injection is a specialized chemotherapy medication that belongs to the important class of medicines known as proteasome inhibitors. It consists of the active ingredient Bortezomib. This injection is specifically indicated for the treatment of both multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominantly found in the bone marrow, where these cells proliferate abnormally. Mantle cell lymphoma is a less common but serious type of cancer primarily affecting the lymph nodes. This medication is often used concomitantly, or in combination, with other chemotherapy medicines such as pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone, or thalidomide, particularly for patients who have not yet started treatment and are ineligible for a blood stem cell transplant.

The common side effects that are likely to be associated with Myezom 2mg Injection include pneumonia, loss of appetite, altered sensitivity, tingling and burning sensations of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, various infections, itching, redness, dehydration, and general stomach problems. It is important to inform your physician if any of these side effects become bothersome or persist for an extended period.

It is crucial to inform your doctor if you are allergic to Myezom 2mg Injection or any of its ingredients. You should not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, it is essential to let your physician know if you are suffering from conditions such as neuropathy (malfunctioning nerves), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a condition characterized by a low platelet count), neutropenia (a low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), or hepatic disorders (liver problems). Additionally, you must inform your doctor if you have diabetes, because this injection can affect your blood glucose levels.